As the market for weight management and anti-obesity grows rapidly in India, diagnostic players are hoping to cash in on the ...

Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss drug, Wegovy, by up to 37% from its ...

Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...

In a video interview with Sohini Das, newly appointed Eli Lilly India President and General Manager Winselow Tucker outlines ...

Eli Lilly's Mounjaro became India's highest-selling drug in October with ₹100 crore sales. The anti-obesity treatment now leads a fast-growing market for GLP-1 and metabolic therapies.

Meghan Trainor is reclaiming her health and body after a gestational diabetes scare during pregnancy. She's now strength ...

Modern weight-loss medications like Ozempic and Mounjaro, originally for diabetes, are gaining attention for their ability to ...

Wegovy’s key competitor is Eli Lilly’s GLP-1 drug Mounjaro (tirzepatide), which became India’s top-selling medicine in ...

Eli Lilly’s anti-obesity and diabetes drug Mounjaro has become the No. 1 brand by sales value in the Indian Pharmaceutical Market (IPM) for the first time in the month of October. The drug clocked ...

Wegovy’s price cut follows Mounjaro’s success in IndiaIndia key market for Novo Nordisk and Eli Lilly’s obesity drugsWegovy’s ...